Latest news with #FreeStockAnalysis
Yahoo
28-05-2025
- Business
- Yahoo
Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings
Phreesia (PHR) reported $115.94 million in revenue for the quarter ended April 2025, representing a year-over-year increase of 14.5%. EPS of -$0.07 for the same period compares to -$0.35 a year ago. The reported revenue represents a surprise of +1.09% over the Zacks Consensus Estimate of $114.69 million. With the consensus EPS estimate being -$0.13, the EPS surprise was +46.15%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average healthcare services Clients: 4,411 compared to the 4,373 average estimate based on three analysts. Patient payment volume: $1.31 billion compared to the $1.25 billion average estimate based on three analysts. Payment facilitator volume percentage: 82% versus 81.3% estimated by two analysts on average. Revenus- Subscription and related services: $54.36 million versus $52.43 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +16.3% change. Revenus- Network solutions: $31.66 million versus the six-analyst average estimate of $33.40 million. The reported number represents a year-over-year change of +15.5%. Revenus- Payment processing fees: $29.93 million compared to the $28.87 million average estimate based on six analysts. The reported number represents a change of +10.6% year over year. View all Key Company Metrics for Phreesia here>>>Shares of Phreesia have returned +0.4% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Phreesia, Inc. (PHR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23-05-2025
- Business
- Yahoo
Bear of the Day: YETI (YETI)
YETI Holdings, Inc. (YETI) cut guidance in May 2025 due to the impact of the tariffs. This Zacks Rank #5 (Strong Sell) is now expected to see a double-digit decline in earnings this year. YETI is a designer, retailer and distributor of outdoor products worldwide. This includes coolers, drinkware, backpacks and bags. On May 8, 2025, YETI reported its first quarter 2025 results and beat on the Zacks Consensus by $0.04. Earnings were $0.31 compared to the consensus of $0.27. This was the 5th earnings beat in a row. Net sales rose 3% to $351.1 million from $341.4 million a year ago. Direct-to-consumer sales rose 4% to $196.2 million primarily due to growth in Coolers & Equipment. While Wholesale channel sales rose just 1% to $154.9 million, also due to growth in Coolers & Equipment. However, the first quarter seems like a different world as Liberation Day tariffs changed the business in April. YETI already had a plan for supply chain diversification, which is ahead of plan. It is aggressively diversifying its sourcing out of China. It expects, by the end of 2025, to have limited exposure to future goods sourced from China. Less than 5% of its total costs of goods will be related to products from China, for the U.S. market. YETI's ability to generate cash is expected to be intact, even with the disruption from the tariff impacts. But while it is mitigating the tariffs, sales and earnings are still expected to be impacted. For 2025, adjusted sales are expected to increase between 1% and 4%, down from its prior projection of 5% to 7%. Earnings are now expected to be in the range of $1.96 to $2.02, down from the prior projection of $2.90 to $2.95. Not surprisingly, the analysts had to cut their estimates to get in line with the new guidance. 10 estimates were cut in the last 30 days for 2025. The Zacks Consensus fell to $2.04 from $2.88. That's down 25.3% from 2024, when YETI made $2.73. 10 estimates were also cut for 2026. You can see the results on the price and consensus chart. Image Source: Zacks Investment Research YETI was a pandemic winner as people headed outdoors. But since 2022, it's been tougher. Shares are down double digits over the last year. Image Source: Zacks Investment Research It's cheap. It trades with a forward price-to-earnings (P/E) ratio of just 14.6. A P/E under 15 usually indicates value. YETI has a strong balance sheet. It had cash of $259 million as of the end of the first quarter and total debt of $77 million. However, it lowered its 2025 free cash flow guidance to a range of $100 to $125 million from $200 million due to the impact from supply chain disruptions as well as higher tariff cost. Investors interested in YETI might want to wait for more certainty on the tariff fall-out before jumping in. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report YETI Holdings, Inc. (YETI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
Should I Buy UnitedHealth Stock Now That it's Half-Off?
One word to describe this chart…yikes. UnitedHealth (UNH) shares were trading near $600 ahead of its April earnings report. The company delivered $7.20 on revenues of $109.6 billion. That missed on both top and bottom line. To go along with it, the company cut its outlook, nothing heightened care activity indications within UNH's Medicare Advantage business. Tuesday, the company announced that CEO Andrew Witty would be stepping down and the company was suspending its 2025 outlook, expecting a return to growth in 2026. That took shares down $67.37 or 17.79% to $311.38 into the bell. With the stock nearly slashed in half and a monster 58 million shares traded, is it finally time to dip the proverbial toe in the water on UNH? Moving Averages: Bartosiak starts by examining the stock's moving averages, such as the 50-day and 200-day moving averages. He points out the significance of crossovers and divergences between these averages, which can indicate potential trend changes. Support and Resistance Levels: Bartosiak identifies key support and resistance levels on the chart. These levels act as barriers that the stock price must breach or hold above, providing traders with critical decision points. Chart Patterns: He discusses chart patterns like head and shoulders, cup and handle, or flags, and their relevance in predicting future price movements. These patterns can offer valuable insights into potential bullish or bearish trends. Volume Analysis: He emphasizes the importance of volume analysis in confirming price trends. An increase in trading volume during a breakout or breakdown can validate the significance of a price move. Dave Bartosiak's technical analysis approach adds depth to our understanding UnitedHealth's stock chart. By paying attention to moving averages, support and resistance levels, chart patterns, technical indicators, and volume, he equips investors with a comprehensive toolkit for making well-informed decisions in the stock market. Remember, while technical analysis is a valuable tool, it's important to consider other factors like fundamental analysis and market sentiment before making investment choices. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-05-2025
- Business
- Yahoo
Groupon Posts Surprize Q1 Profit, Raises Annual Outlook
Groupon Inc. (NASDAQ:GRPN) shares are trading higher premarket on Thursday. The company reported first-quarter financial results after the market closed on Wednesday. The company reported revenue of $117.2 million, beating estimates of $115.5 million, according to Benzinga Pro. Revenue was down 5% (+4% FX-neutral) compared to last year's first quarter (Y/Y).Groupon reported an EPS of 18 cents, versus estimates for a loss of 11 cents. Gross billings totaled $386.5 million in the first quarter, up 1% Y/Y (+2% Y/Y FX-neutral). Dusan Senkypl, CEO of Groupon said, 'With North America Local Billings accelerating to double-digit growth and our local marketplace strategy showing green shoots across geographies and verticals, we are building momentum and expect to continue to accelerate our growth.' Unit sales were 8.5 million, down 6% year over year, and active customers were 15.5 million as of March 31, down 4% year over year. Gross profit dipped 4% Y/Y to $106.3 million, and adjusted EBITDA declined to $15.3 million from $19.5 million in the prior year quarter. Groupon's operating cash flow was flat, and free cash outflow was $3.8 million in the quarter. The company ended the period with $226.8 million in cash and cash equivalents. Outlook: Groupon expects second-quarter revenue of $121 million to $123 million vs. consensus of $119.66 million. The company expects second-quarter billings to be up 4% to 7% year over year and adjusted EBITDA to be between $14 million and $17 million. Groupon guided for full-year billings growth of 3% to 4% (vs. 2% to 4% prior), and reaffirms revenue outlook of $493 million to $500 million (vs. street view of $496.96 million). Price Action: GRPN shares are up 12.2% at $19.06 premarket at the last check on Thursday. Read Next:Photo by Casimiro PT via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? GROUPON (GRPN): Free Stock Analysis Report This article Groupon Posts Surprize Q1 Profit, Raises Annual Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-05-2025
- Business
- Yahoo
Here's What Key Metrics Tell Us About Embraer (ERJ) Q1 Earnings
Embraer (ERJ) reported $1.1 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 23%. EPS of $0.40 for the same period compares to -$0.07 a year ago. The reported revenue represents a surprise of -0.88% over the Zacks Consensus Estimate of $1.11 billion. With the consensus EPS estimate being $0.21, the EPS surprise was +90.48%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Embraer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Commercial Aviation : $202 million versus $248.84 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.5% change. Revenue- Services & Support : $425 million compared to the $405.80 million average estimate based on two analysts. The reported number represents a change of +16.1% year over year. Revenue- Defense & Security : $139 million versus the two-analyst average estimate of $138.79 million. The reported number represents a year-over-year change of +71.6%. Revenue- Executive Aviation: $323 million versus $316.56 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +34.6% change. View all Key Company Metrics for Embraer here>>> Shares of Embraer have returned +14.5% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Embraer-Empresa Brasileira de Aeronautica (ERJ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
